Benztropine
Benztropine is an anticholinergic medication primarily used to treat Parkinson's disease and manage movement disorders caused by certain psychiatric medications. It helps restore the balance of chemicals in the brain that control movement and coordination. This medication is typically prescribed when patients experience stiffness, tremors, or involuntary movements.
Benztropine is an anticholinergic drug used to treat Parkinson's disease symptoms and medication-induced movement disorders.
Key facts at a glance
- ATC
- N04AC01
- RxNorm
- 1424
- Generic
- Benztropine
- Class
- atc-n04
- Brands
- —
- Availability
- rx
- Lactation
- unknown
- Routes
- oral
- Forms
- injection, tablet
- Regions
- US, EU, CN, JP
- Monitoring
- —
This page is for informational purposes only.
Do not use this information to diagnose yourself or to replace a physician's advice. Always consult a qualified healthcare provider before starting, stopping, or changing any medication. If you believe you are experiencing a medical emergency, call your local emergency number immediately.
Dosage and administration
- Usual dose
- 500mg twice daily
- Maximum
- consult physician
- Frequency
- every 12 hours
- Instructions
- Follow physician instructions
- Duration limits
- as prescribed
- Monitoring
- standard
- Usual dose
- 250mg twice daily
- Maximum
- consult physician
- Frequency
- every 12 hours
- Instructions
- Follow physician instructions
- Duration limits
- as prescribed
- Monitoring
- standard
- Usual dose
- 400mg daily
- Maximum
- consult physician
- Frequency
- once daily
- Instructions
- Follow physician instructions
- Duration limits
- as prescribed
- Monitoring
- standard
Overdose information
Special Populations
11 groupspregnancy
first trimesteravoid if possible
avoid use during first trimester unless benefits outweigh risks
regular fetal monitoring
Use with caution and monitor for adverse effects.
pregnancy
second trimesteruse lowest effective dose
use only if clearly needed for maternal condition
fetal growth monitoring
Use with caution and monitor for adverse effects.
pregnancy
third trimesteravoid if possible
avoid close to delivery due to potential effects on newborn
neonatal assessment for anticholinergic effects
Use with caution and monitor for adverse effects.
lactation
breastfeedingdiscontinue breastfeeding or avoid drug
benztropine crosses into breast milk; not recommended during breastfeeding
monitor infant for anticholinergic symptoms
Use of this medication in this population requires careful consideration of risks and benefits.
geriatric
elderlyreduce dose
start with lowest dose; monitor closely for confusion sedation and anticholinergic effects
cognitive function monitoring
Use with caution and monitor for adverse effects.
pediatric_age
children adolescentsweight-based dosing with extreme caution
use only for acute dystonic reactions; not for chronic use in children
monitor for behavioral changes and anticholinergic effects
Use with caution and monitor for adverse effects.
renal_impairment
mild to moderateno significant adjustment needed
use with caution; monitor renal function
renal function monitoring
Use with caution and monitor for adverse effects.
renal_impairment
severereduce dose by 25-50%
use with extreme caution; dose reduction recommended
frequent renal function and drug level monitoring
Use with caution and monitor for adverse effects.
hepatic_impairment
mild to moderateuse with caution
monitor liver function; adjust dose if needed
liver function monitoring
Use with caution and monitor for adverse effects.
hepatic_impairment
severereduce dose significantly
avoid if possible; if needed use very low doses
frequent liver function and drug level monitoring
Use with caution and monitor for adverse effects.
alcohol_users
concurrent useavoid combination
concurrent use with alcohol is not recommended due to additive CNS depression
monitor for excessive sedation and respiratory depression
Use of this medication in this population requires careful consideration of risks and benefits.
Statistics and clinical data
FDA approval year
Original FDA approval for Benztropine mesylate (Cogentin)
Drug class
Pharmacological classification N04BA01
Primary indications
FDA-approved therapeutic uses
Mechanism of action
Central anticholinergic activity blocking muscarinic receptors
Treats Parkinson's disease and drug-induced extrapyramidal symptoms (such as stiffness, tremors, and involuntary movements) associated with antipsychotic medications. May be used for tremor, rigidity, and bradykinesia in various parkinsonian syndromes.
Blocks the action of acetylcholine, a neurotransmitter, in the central nervous system. By restoring the balance between acetylcholine and dopamine, it helps reduce overactive cholinergic activity that contributes to movement disorders.
May cause drowsiness, dry mouth, blurred vision, or constipation. Should be used cautiously in elderly patients due to increased sensitivity to side effects. Can worsen symptoms in patients with tardive dyskinesia. Not for treating movement problems caused by conditions other than Parkinson's or drug-induced EPS.
Contraindications
Conditions and patient states where this medication should be avoided or used with caution.
Do not use (1)
Known allergy to this medication or its components
Use caution (1)
Consult healthcare provider for benefits vs risks assessment
Official drug label
WellAlly may earn a referral fee from linked resources at no extra cost to you. Editorial content is never influenced by commercial relationships.
This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 24, 2026. · Read our editorial policy